News

During Flu Season Risk of Heart Failure Rises

Researchers explore legitimacy of the “long-held notion” that there is a connection between flu and heart failure risk.


 

A study of > 450,000 adults has “confirmed the long-held notion” that flu and heart failure are connected. The Atherosclerosis Risk in Communities study (ARIC), led by a VA researcher, found influenza significantly increased the risk of hospitalization for heart failure.

Every flu season about 36,000 people die, and > 200,000 are hospitalized due to flu, which is known to be associated with a higher risk of cardiovascular events. Several mechanisms likely contribute: Some form of immunocompromise is thought to be a key link. But few studies, the researchers note, have explored the temporal association between influenza activity and hospitalizations, particularly those caused by heart failure.

In ARIC, the researchers analyzed hospitalization data for adults aged 35 to 84 years between 2010 and 2014 in geographically diverse communities in Mississippi, Minnesota, North Carolina, and Maryland. They correlated those data with reports of influenza activity from the CDC Surveillance Network.

A 5% monthly increase in influenza activity was associated with a 24% relative increase in heart failure hospitalization rates. Myocardial infarction hospitalizations did not rise significantly. The most pneumonia and influenza-associated deaths were during the 2012-2013 season, when influenza-like illness (ILI) activity was highest, and the fewest deaths occurred during 2011-2012, when ILI activity was lowest. The model suggests that in a month with high influenza activity, about 19% of hospitalizations could be attributable to influenza, the researchers say.

“The study’s findings support VA’s aggressive effort every year to provide veterans with influenza vaccine,” said VA Secretary Robert Wilkie. Although the flu season is winding down, he added, it is not too late for veterans—and others—to get vaccinated.

Recommended Reading

Genetic variant increases stroke risk in childhood cancer survivors
Federal Practitioner
CV disease and mortality risk higher with younger age of type 2 diabetes diagnosis
Federal Practitioner
Effects of Process Improvement on Guideline-Concordant Cardiac Enzyme Testing
Federal Practitioner
Alirocumab reduces both type 1 and 2 MIs
Federal Practitioner
Dapagliflozin’s cardiovascular benefits bloom in T2D with prior MI
Federal Practitioner
New data further suggest that stress does a number on the CV system
Federal Practitioner
Coughing Won’t Pay the Bills
Federal Practitioner
Low LDL cholesterol may increase women’s risk of hemorrhagic stroke
Federal Practitioner
Canagliflozin lowers kidney failure risk in T2D: CREDENCE
Federal Practitioner
Poor response to statins hikes risk of cardiovascular events
Federal Practitioner